251 related articles for article (PubMed ID: 18424514)
21. Characterization of the Ubiquitin and ISG15 Deconjugase Activity of SARS-CoV-1 and SARS-CoV-2 Papain-Like Protease.
Nayak D; Dos Santos Bury P; Drag M; Nijkerk AN; El Oualid F; Olsen SK
Methods Mol Biol; 2023; 2591():171-188. PubMed ID: 36350549
[TBL] [Abstract][Full Text] [Related]
22. Murine coronavirus ubiquitin-like domain is important for papain-like protease stability and viral pathogenesis.
Mielech AM; Deng X; Chen Y; Kindler E; Wheeler DL; Mesecar AD; Thiel V; Perlman S; Baker SC
J Virol; 2015 May; 89(9):4907-17. PubMed ID: 25694594
[TBL] [Abstract][Full Text] [Related]
23. Deubiquitinating enzyme purification, assay inhibitors, and characterization.
Russell NS; Wilkinson KD
Methods Mol Biol; 2005; 301():207-19. PubMed ID: 15917634
[TBL] [Abstract][Full Text] [Related]
24. Proteolytic processing, deubiquitinase and interferon antagonist activities of Middle East respiratory syndrome coronavirus papain-like protease.
Yang X; Chen X; Bian G; Tu J; Xing Y; Wang Y; Chen Z
J Gen Virol; 2014 Mar; 95(Pt 3):614-626. PubMed ID: 24362959
[TBL] [Abstract][Full Text] [Related]
25. Cellular Assays for Dynamic Quantification of Deubiquitinase Activity and Inhibition.
Moghadasi SA; Moraes SN; Harris RS
J Mol Biol; 2023 Dec; 435(23):168316. PubMed ID: 37858708
[TBL] [Abstract][Full Text] [Related]
26. Deubiquitinase function of arterivirus papain-like protease 2 suppresses the innate immune response in infected host cells.
van Kasteren PB; Bailey-Elkin BA; James TW; Ninaber DK; Beugeling C; Khajehpour M; Snijder EJ; Mark BL; Kikkert M
Proc Natl Acad Sci U S A; 2013 Feb; 110(9):E838-47. PubMed ID: 23401522
[TBL] [Abstract][Full Text] [Related]
27. Specific and covalent targeting of conjugating and deconjugating enzymes of ubiquitin-like proteins.
Hemelaar J; Borodovsky A; Kessler BM; Reverter D; Cook J; Kolli N; Gan-Erdene T; Wilkinson KD; Gill G; Lima CD; Ploegh HL; Ovaa H
Mol Cell Biol; 2004 Jan; 24(1):84-95. PubMed ID: 14673145
[TBL] [Abstract][Full Text] [Related]
28. Chemistry-based functional proteomics: mechanism-based activity-profiling tools for ubiquitin and ubiquitin-like specific proteases.
Hemelaar J; Galardy PJ; Borodovsky A; Kessler BM; Ploegh HL; Ovaa H
J Proteome Res; 2004; 3(2):268-76. PubMed ID: 15113103
[TBL] [Abstract][Full Text] [Related]
29. Strategies for assaying deubiquitinating enzymes.
Kang SH; Park JJ; Chung SS; Bang OS; Chung CH
Methods Enzymol; 2005; 398():500-8. PubMed ID: 16275354
[TBL] [Abstract][Full Text] [Related]
30. Taking it step by step: mechanistic insights from structural studies of ubiquitin/ubiquitin-like protein modification pathways.
Capili AD; Lima CD
Curr Opin Struct Biol; 2007 Dec; 17(6):726-35. PubMed ID: 17919899
[TBL] [Abstract][Full Text] [Related]
31. Kinetic and mechanistic studies on the hydrolysis of ubiquitin C-terminal 7-amido-4-methylcoumarin by deubiquitinating enzymes.
Dang LC; Melandri FD; Stein RL
Biochemistry; 1998 Feb; 37(7):1868-79. PubMed ID: 9485312
[TBL] [Abstract][Full Text] [Related]
32. Ubiquitin and ubiquitin-like specific proteases targeted by infectious pathogens: Emerging patterns and molecular principles.
Edelmann MJ; Kessler BM
Biochim Biophys Acta; 2008 Dec; 1782(12):809-16. PubMed ID: 18817868
[TBL] [Abstract][Full Text] [Related]
33. Characterization of selective ubiquitin and ubiquitin-like protease inhibitors using a fluorescence-based multiplex assay format.
Tian X; Isamiddinova NS; Peroutka RJ; Goldenberg SJ; Mattern MR; Nicholson B; Leach C
Assay Drug Dev Technol; 2011 Apr; 9(2):165-73. PubMed ID: 21133675
[TBL] [Abstract][Full Text] [Related]
34. Selectivity in ISG15 and ubiquitin recognition by the SARS coronavirus papain-like protease.
Lindner HA; Lytvyn V; Qi H; Lachance P; Ziomek E; Ménard R
Arch Biochem Biophys; 2007 Oct; 466(1):8-14. PubMed ID: 17692280
[TBL] [Abstract][Full Text] [Related]
35. Chemical biology tools to study Deubiquitinases and Ubl proteases.
Gorka M; Magnussen HM; Kulathu Y
Semin Cell Dev Biol; 2022 Dec; 132():86-96. PubMed ID: 35216867
[TBL] [Abstract][Full Text] [Related]
36. To ubiquitinate or to deubiquitinate: it all depends on the partners.
Marfany G; Denuc A
Biochem Soc Trans; 2008 Oct; 36(Pt 5):833-8. PubMed ID: 18793146
[TBL] [Abstract][Full Text] [Related]
37. Inhibitors of Deubiquitinating Enzymes Interfere with the SARS-CoV-2 Papain-like Protease and Block Virus Replication In Vitro.
Große M; Setz C; Rauch P; Auth J; Morokutti-Kurz M; Temchura V; Schubert U
Viruses; 2022 Jun; 14(7):. PubMed ID: 35891385
[TBL] [Abstract][Full Text] [Related]
38. Isopeptidases in anticancer therapy: looking for inhibitors.
Sgorbissa A; Potu H; Brancolini C
Am J Transl Res; 2010 May; 2(3):235-47. PubMed ID: 20589164
[TBL] [Abstract][Full Text] [Related]
39. Strategies for the identification of novel inhibitors of deubiquitinating enzymes.
Goldenberg SJ; McDermott JL; Butt TR; Mattern MR; Nicholson B
Biochem Soc Trans; 2008 Oct; 36(Pt 5):828-32. PubMed ID: 18793145
[TBL] [Abstract][Full Text] [Related]
40. Punaglandins, chlorinated prostaglandins, function as potent Michael receptors to inhibit ubiquitin isopeptidase activity.
Verbitski SM; Mullally JE; Fitzpatrick FA; Ireland CM
J Med Chem; 2004 Apr; 47(8):2062-70. PubMed ID: 15056003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
